Novara Therapeutics, an antiviral drug discovery company, has secured $23m in Series A financing to support the development of capsid-targeting antivirals to treat chronic hepatitis B (HBV) and HIV infections. The company's antiviral ...
Tags: antiviral drug discovery company, chronic hepatitis, HIV infections